Evidence map›Paper›PMID 31823770›Full record

ArticleCell communication and signaling : CCS2019

1,25-(OH)

Dan Liu, Yu-Xuan Fang, Xia Wu, Wei Tan, Wei Zhou, Yu Zhang, Yan-Qing Liu, Guo-Qing Li

Open access · goldAbstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Observational
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Dan LiuDepartment of Pathology, Clinical Medical College, Yangzhou University, Yangzhou, 225000, People's Republic of China.
Yu-Xuan FangDepartment of Rheumatology and Immunology, Affiliated Hospital of Yangzhou University, Yangzhou University, No. 368, Hangjiang Road, Yangzhou, Jiangsu Province, 225000, People's Republic of China.
Xia WuDepartment of Rheumatology and Immunology, Affiliated Hospital of Yangzhou University, Yangzhou University, No. 368, Hangjiang Road, Yangzhou, Jiangsu Province, 225000, People's Republic of China.
Wei TanDepartment of Rheumatology and Immunology, Affiliated Hospital of Yangzhou University, Yangzhou University, No. 368, Hangjiang Road, Yangzhou, Jiangsu Province, 225000, People's Republic of China.
Wei ZhouDepartment of Rheumatology and Immunology, Affiliated Hospital of Yangzhou University, Yangzhou University, No. 368, Hangjiang Road, Yangzhou, Jiangsu Province, 225000, People's Republic of China.
Yu ZhangMedical College of Yangzhou University, Yangzhou, 225000, People's Republic of China.
Yan-Qing LiuMedical College of Yangzhou University, Yangzhou, 225000, People's Republic of China.
Guo-Qing LiDepartment of Rheumatology and Immunology, Affiliated Hospital of Yangzhou University, Yangzhou University, No. 368, Hangjiang Road, Yangzhou, Jiangsu Province, 225000, People's Republic of China. Guoqing1007@163.com.
Yangzhou University · CNDalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecent evidence has suggested that the 1,25(OH)

methodsInitially, the levels of 1,25(OH)

resultsAmong the SLE patients, the levels of 1,25(OH)

conclusionThis study indicated that 1,25-(OH)

Indexed as

AdolescentAdultAgedAnimalsCalcitriolChildCyclin-Dependent Kinase Inhibitor p27Dietary SupplementsDown-RegulationFemaleHumansLupus Erythematosus, SystemicMaleMiceMice, Inbred C57BLMice, KnockoutCalcitriolCyclin-Dependent Kinase Inhibitor p27Receptors, CalcitriolSKP2 protein, humanS-Phase Kinase-Associated ProteinsVDR protein, human1,25(oh)2D3Inflammatory factorsp27Renal injurySkp2Systemic lupus erythematosusVitamin D receptor

Identifiers

PMID31823770
PMCPMC6905035
OpenAlexW2995551919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.